Insight Medbotics appoints new President & CEO, Paul Chipperton

April 29, 2021

HAMILTON, ON, April 29, 2021 /CNW/ – The Board of Directors for Insight Medbotics, a start-up founded by MDA and the Centre for Surgical Invention and Innovation (CSii), are pleased to announce the appointment of Paul Chipperton as the company’s Chief Executive Officer & President.

Mr. Chipperton will be responsible for ensuring the successful execution of existing projects, including the IGAR (Image Guided Automated Robot), the world’s first Magnetic Resonance Imaging (MRI) guided breast cancer robot.

‍

About Insight Medbotics

Insight Medbotics is an interventional oncology company advancing precision in cancer care through its MRI-compatible robotics. IGAR, the company’s flagship MRI-compatible robot, has been clinically demonstrated. As the only company to receive a FDA 510(k) clearance for use of a robot with an MRI, Insight Medbotics is now developing Glenn™, a next-generation platform designed to expand access to MRI-guided precision for urologists. For more information, visit www.insightmedbotics.com.
Products
About Us
Meet GlennRequest a Demo
NewsThe TeamContact Us
Privacy Policy
|
 Terms of Use
GlennTM is under development and is not FDA cleared for prostate indication in the US or available for sale. GlennTM is a trademark of Insight Medbotics Inc.
© 2026 Insight Medbotics Inc. All rights reserved. For illustrative purposes only and subject to change without notice.
v071526